Back

Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a Mendelian randomization study

26 August 2023 (08:48 - 09:07)
Organised by: Logo
Congress Presentation Part of: Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Klaudyna Grzelakowska

Antoni Jurasz University Hospital No 1, Bydgoszcz (Poland)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on cardiovascular residual risk management: role of triglycerides and remnant cholesterol
Professor J. Jukema (Leiden, NL)
Slides Video
Presentation thumbnail
Eicosapentaenoic acid, arachidonic acid, and triglyceride levels mediate most of the benefit of icosapent ethyl in REDUCE-IT
Professor D. Bhatt (New York City, US)
Abstract Slides Video
Presentation thumbnail
Low HDL cholesterol and hyperglicemia are metabolic syndrome components associated with plaque progression in patients with chronic coronary syndrome: a PARADIGM study
Doctor D. Neglia (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 08:48 CET
You may be interested in
thumbnail
Congress Session
Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease
thumbnail
Congress Presentation
The influence of remnant cholesterol on ischemic stroke and its subtypes
thumbnail
Congress Presentation
We should target triglycerides to decrease cardiovascular risk: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources